Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Heel 060 Tab 4 D Tablet is a Health Canada–registered human drug (DIN 01969269) held by Biologische Heilmittel Heel GmbH, containing Pulsatilla. Health Canada lists its status as Cancelled Post Market (status date 10 Oct 1997). Nexara Health has matched 7 registrations of Pulsatilla across 1 other regulated market.

Health Canada registration

DIN01969269
Brand nameHeel 060 Tab
Active ingredientPulsatilla
Strength4 D
Dosage formTablet
RouteOral
CompanyBiologische Heilmittel Heel GmbH
StatusCancelled Post Market — 10 Oct 1997
ClassHuman
ATC
AHFS92:02.00* ; See footnote
Regulator recordHealth Canada DPD entry · Product monograph

Pulsatilla registered in other markets

7 registrations of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
United StatesPulsatillaTrue Botanica, LLCGlobulelistedFDA NDC
United StatesPulsatillaHistorical RemediesPelletlistedFDA NDC
United StatesPulsatillaRxhomeo Private Limited d.b.a. Rxhomeo, IncPelletlistedFDA NDC
United StatesPulsatillaRxhomeo Private Limited d.b.a. Rxhomeo, IncLiquidlistedFDA NDC
United StatesPulsatilla 200CNatural Creations, IncLiquidlistedFDA NDC
United StatesPulsatilla 200ckSevene UsaPelletlistedFDA NDC
United StatesPulsatilla 7131Professional Complementary Health FormulasLiquidlistedFDA NDC

See every manufacturer of Pulsatilla worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Heel 060 Tab (DIN 01969269) marketed in Canada?

No. Health Canada lists DIN 01969269 as Cancelled Post Market as of 10 Oct 1997.

Who holds the Canadian licence for this product?

Biologische Heilmittel Heel GmbH is the company of record in the Health Canada Drug Product Database.

Is Pulsatilla registered outside Canada?

Yes — Nexara Health has matched 7 registrations in 1 other market (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 01969269, status date 1997-10-10; national medicine registries: FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 01969269, status date 1997-10-10; national medicine registries: FDA NDC.

Health Canada Drug Product Database (DPD), DIN 01969269, status date 1997-10-10; national medicine registries: FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.